News

LMAG presentation
02/08/2022
IRLA’s board director Paul Corver said “I was pleased to be asked to participate on a panel discussing all aspects of legacy and presenting to the London Market Actuaries Group.  Even more pleased to have done this in person......More

Clyde & Co
20/07/2022
NICE approves use of nivolumab and ipilimumab as first-line treatment for mesothelioma...More

Davies completes acquisition of Asta
19/07/2022
...More